Are you Dr. Rosa?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 14 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
655 W 8th St
Dept Of
Jacksonville, FL 32209Phone+1 904-244-5326
Summary
- Dr. Marilin (Rosa Gallardo) Rosa, MD is a board certified pathologist in Jacksonville, Florida. She is currently licensed to practice medicine in Florida and Kentucky. She is affiliated with H. Lee Moffitt Cancer Center and Research Institute and is an Assistant Professor at Immunology.
Education & Training
- University of Louisville School of MedicineFellowship, Cytopathology, 2006 - 2007
- University of Puerto RicoResidency, Pathology-Anatomic and Clinical, 2003 - 2006
- Universidad de Ciencias MedicasClass of 1999
Certifications & Licensure
- FL State Medical License 2007 - 2025
- KY State Medical License 2006 - 2025
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Cytopathology
Clinical Trials
- Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases Start of enrollment: 2021 Nov 30
- Study of Screening Brain MRIs in Stage IV Breast Cancer Start of enrollment: 2021 Dec 21
Roles: Sub-Investigator
Publications & Presentations
PubMed
- 2 citationsClinicopathologic Predictors of Clinical Outcomes in Mammary Adenoid Cystic Carcinoma: A Multi-institutional Study.Thaer Khoury, Marilin Rosa, Anupma Nayak, Rouzan Karabakhtsian, Oluwole Fadare
Modern Pathology. 2023-02-01 - 8 citationsAuthor Correction: Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial.Hatem Soliman, Deanna Hogue, Hyo Han, Blaise Mooney, Ricardo Costa
Nature Medicine. 2023-12-01 - 31 citationsA Phase I Trial of Talimogene Laherparepvec in Combination with Neoadjuvant Chemotherapy for the Treatment of Nonmetastatic Triple-Negative Breast CancerHatem Soliman, Deanna Hogue, Hyo S. Han, Blaise Mooney, Ricardo Costa
Clinical Cancer Research. 2021-02-15